Elanco (ELAN) CFO Robert VanHimbergen Receives Deferred Stock Award
$ELAN · Elanco Animal Health IncResearch Summary
AI-generated summary of this SEC filing
Elanco (ELAN) CFO Robert VanHimbergen Receives Deferred Stock Award
What Happened
Robert M. VanHimbergen, Elanco’s Executive Vice President and Chief Financial Officer, was granted 8.042 deferred stock units on September 4, 2026. The units were recorded at $24.50 each, a total grant value of about $197. This transaction is reported as an award/grant (transaction code A) and is a compensation-related issuance rather than an open-market purchase.
Key Details
- Transaction date: 2026-09-04; filing date: 2026-09-09 (filed 5 days after the transaction). This appears to be a late Form 4 filing.
- Grant: 8.042 deferred stock units at $24.50 per unit; total value reported ≈ $197 (derivative grant).
- Shares owned after transaction: Not specified in the provided filing.
- Footnotes: Each deferred stock unit equals the right to one share or the cash equivalent (F1). Units settle in cash or shares after termination or in a specified future year per the Executive Deferral and Stock Match Plan (F2).
- Transaction type code: A = Award/Grant; reported as a derivative award.
Context
Deferred stock units are a form of compensation and do not represent immediately tradable shares; they typically convert to company stock or cash at a later date or upon termination, per the plan. Because this is a small, routine compensation award (~$197), it should not be interpreted as an immediate buy or sell signal about management’s market view. The late filing delays public disclosure and is worth noting for timeliness considerations.